1492 Capital Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-26
| Closed | -$117K | – | 112 |
|
|
2023
Q2 | $117K | Hold |
26
| – | – | 0.07% | 95 |
|
|
2023
Q1 | $67.8K | Hold |
26
| – | – | 0.04% | 97 |
|
|
2022
Q4 | $66.6K | Hold |
26
| – | – | 0.04% | 99 |
|
|
2022
Q3 | $103K | Hold |
26
| – | – | 0.07% | 102 |
|
|
2022
Q2 | $68K | Hold |
26
| – | – | 0.04% | 106 |
|
|
2022
Q1 | $84K | Sell |
26
-2
| -7% | -$6.46K | 0.04% | 102 |
|
|
2021
Q4 | $177K | Hold |
28
| – | – | 0.09% | 93 |
|
|
2021
Q3 | $261K | Hold |
28
| – | – | 0.13% | 87 |
|
|
2021
Q2 | $285K | Sell |
28
-1
| -3% | -$10.2K | 0.15% | 83 |
|
|
2021
Q1 | $546K | Sell |
29
-10
| -26% | -$188K | 0.31% | 63 |
|
|
2020
Q4 | $237K | Hold |
39
| – | – | 0.14% | 80 |
|
|
2020
Q3 | $141K | Hold |
39
| – | – | 0.11% | 80 |
|
|
2020
Q2 | $152K | Hold |
39
| – | – | 0.13% | 80 |
|
|
2020
Q1 | $74K | Buy |
+39
| New | +$74K | 0.09% | 75 |
|